Literature DB >> 13683312

Clinical investigations on a new intramuscular haematinic.

N S ANDERSSON.   

Abstract

Keywords:  ANEMIA, HYPOCHROMIC/therapy; CITRATES/therapy; IRON/therapy; SORBITOL/therapy

Mesh：

Substances：

Year:  1961        PMID： 13683312      PMCID： PMC1969635          DOI： 10.1136/bmj.2.5247.275

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  On the carcinogenicity of an iron-dextran complex.

Authors:  A HADDOW; E S HORNING
Journal:  J Natl Cancer Inst       Date:  1960-01       Impact factor: 13.506

2.  Induction of sarcoma in the rat by iron-dextran complex.

Authors:  H G RICHMOND
Journal:  Br Med J       Date:  1959-04-11

3.  Metabolism of 59Fe-dextran complex in human subjects.

Authors:  A J GRIMES; M S HUTT
Journal:  Br Med J       Date:  1957-11-09

4.  Intramuscular iron therapy in iron-deficiency anaemia.

Authors:  I M BAIRD; D A PODMORE
Journal:  Lancet       Date:  1954-11-06       Impact factor: 79.321
  4 in total
  5 in total

1.  Metabolism of 59Fe-sorbitol complex in man.

Authors:  G WETHERLEY-MEIN; J G BUCHANAN; U H GLASS; L C PEARCE
Journal:  Br Med J       Date:  1962-06-30

2.  Iron-sorbitol-citrate in pregnancy anaemia.

Authors:  J M SCOTT
Journal:  Br Med J       Date:  1963-08-10

3.  Anaemia in pregnancy.

Authors:  J M SCOTT
Journal:  Postgrad Med J       Date:  1962-04       Impact factor: 2.401

4.  To-day's Drugs.

Authors: 
Journal:  Br Med J       Date:  1963-08-10

5.  The treatment of iron-deficiency anaemia by iron-dextran infusion, with special reference to the effect on blood-grouping, coagulation, sedimentation and haemolysis.

Authors:  B M Groden; J Whitelaw; G Will
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.